PreveCeutical Medical Inc.
OTC: PRVCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Stephen Van Deventer
- Employees
- 7
- Headquarters
- Vancouver, Canada
- IPO year
- 2017
- Market cap
- $6.5M
- Website
- https://www.preveceutical.com
Loading PRVCF…
Loading profile data…Frequently asked questions about PRVCF
What does PreveCeutical Medical Inc. (PRVCF) do?
Vancouver, Canada-based PreveCeutical Medical Inc. operates as a health sciences company, focusing on the creation of both preventative and curative treatments derived from organic and nature-identical substances. The company's innovative pipeline includes a cannabinoid Sol-Gel Delivery system designed for nose-to-brain administration, offering...
Where does PRVCF trade?
PreveCeutical Medical Inc. (PRVCF) trades on the Other OTC.
What sector is PRVCF in?
PreveCeutical Medical Inc. (PRVCF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of PreveCeutical Medical Inc.?
Stephen Van Deventer is the chief executive officer of PreveCeutical Medical Inc. (PRVCF).
Where is PreveCeutical Medical Inc. headquartered?
PreveCeutical Medical Inc. is headquartered in Canada.
Does PRVCF pay a dividend?
PreveCeutical Medical Inc. (PRVCF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PRVCF go public?
PreveCeutical Medical Inc. (PRVCF) completed its initial public offering in 2017.